IMPRS: Biomarker for Early Prediction of COVID-19 Severity Identified

Published on October 21, 2021, by IMPRS for Molecular Organ Biology, this article discusses the discovery of a crucial biomarker, the gene isoform hFwe-Lose. This biomarker, indicating the "fitness degree" of lung epithelial cells, can predict the severity of COVID-19 infection early on. It was found that high expression of hFwe-Lose in lung cells correlates with a higher risk of severe COVID-19 progression, providing a vital tool for early intervention and treatment strategies.

For more information, you can read the full article on IMPRS for Molecular Organ Biology.